Xeris Biopharma (XERS) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free XERS Stock Alerts $1.85 -0.03 (-1.60%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHere's what Wall Street expects from Xeris Biopharma's earnings reportmarkets.businessinsider.com - May 8 at 6:14 PMXeris Biopharma (XERS) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - May 8 at 5:10 AMXeris Biopharma and Beta Bionics join forces to develop dual-hormone pump for diabetesproactiveinvestors.com - May 6 at 10:01 AMXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionicsbusinesswire.com - May 6 at 7:00 AMXeris Biopharma (XERS) to Release Quarterly Earnings on Thursdaymarketbeat.com - May 3 at 9:16 AMPleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stockfinance.yahoo.com - May 2 at 2:44 PMXeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024businesswire.com - May 2 at 7:00 AMXeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutionsfinance.yahoo.com - April 5 at 12:23 PMXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)finance.yahoo.com - April 3 at 6:23 PMXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 2 at 8:50 AMXeris Biopharma (NASDAQ:XERS) Now Covered by Oppenheimermarketbeat.com - March 28 at 8:29 AMXeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for 2024 Growthproactiveinvestors.com - March 18 at 9:49 PMHere's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Resultsfinance.yahoo.com - March 9 at 1:59 PMXeris Biopharma (XERS) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 7:43 PMBrokers Offer Predictions for Xeris Biopharma Holdings, Inc.'s Q2 2024 Earnings (NASDAQ:XERS)marketbeat.com - March 8 at 6:35 AMXeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - March 7 at 2:41 PMXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 7 at 1:01 PMHC Wainwright Boosts Xeris Biopharma (NASDAQ:XERS) Price Target to $6.00marketbeat.com - March 7 at 8:20 AMQ4 2023 Xeris Biopharma Holdings Inc Earnings Callfinance.yahoo.com - March 7 at 12:19 AMXeris Biopharma Shares Drop After Weak 4Q Resultsmarketwatch.com - March 6 at 7:18 PMXeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84Mmsn.com - March 6 at 7:18 PMXERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023investorplace.com - March 6 at 2:00 PMXeris Biopharma secures $200M in capital in debt refinancing deal; sees big 4Q revenue jumpproactiveinvestors.com - March 6 at 9:57 AMXeris Biopharma (NASDAQ:XERS) Issues Earnings Results, Misses Estimates By $0.01 EPSmarketbeat.com - March 6 at 7:49 AMXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Eventsbusinesswire.com - March 6 at 7:02 AMXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capitalbusinesswire.com - March 6 at 7:00 AMXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024businesswire.com - February 28 at 7:00 AM3 Breakout Stocks Under $5 to Buy for More Upsidetheglobeandmail.com - February 23 at 7:13 PMXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Short Interest Down 9.7% in Januarymarketbeat.com - February 15 at 1:58 AMFY2023 Earnings Forecast for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Issued By Leerink Partnrsmarketbeat.com - February 8 at 6:43 AMResearch Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc.'s Q1 2024 Earnings (NASDAQ:XERS)marketbeat.com - February 7 at 8:05 AMXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conferencefinance.yahoo.com - February 5 at 9:27 AMBig Game or Small, Here's How to Go About Stalking a Traderealmoney.thestreet.com - February 3 at 6:45 PMXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease Treatmentmarketwatch.com - January 10 at 11:14 AMXeris Biopharma Shares Climb 12% on Amgen License Agreementmarketwatch.com - January 10 at 11:14 AMWhy Is Xeris Biopharma (XERS) Stock Up 12% Today?msn.com - January 10 at 11:14 AMTraders Buy Large Volume of Call Options on Xeris Biopharma (NASDAQ:XERS)marketbeat.com - January 10 at 10:35 AMXeris Biopharma: Speculative Buy, Size Your Position Accordinglyseekingalpha.com - January 9 at 7:27 AMXeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlookmarketwatch.com - January 4 at 2:58 PMXeris Biopharma sees FY revenue at higher end of guidancemsn.com - January 4 at 9:58 AMXeris Biopharma Updates Its Outlook for 2023finance.yahoo.com - January 4 at 9:58 AMXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024seekingalpha.com - January 1 at 5:43 AMXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024seekingalpha.com - January 1 at 5:43 AMXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 27 at 7:47 AMXeris Biopharma Holdings, Inc. (0A8E.L)sg.finance.yahoo.com - December 27 at 12:35 AMMy Top Small-Cap Stock Pick for 2024 Is a Biotech With a Big Opportunityfinance.yahoo.com - December 20 at 5:47 PMXeris Pharmaceuticals, Inc. (XERS)uk.finance.yahoo.com - December 3 at 2:38 PMPresident & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stockfinance.yahoo.com - November 20 at 8:50 AMXeris Biopharma CEO unveils game-changing drug innovations and record financial successfinance.yahoo.com - November 17 at 2:18 PMAnalysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Xeris Pharmaceuticals (XERS)markets.businessinsider.com - November 14 at 11:53 PM Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. XERS Media Mentions By Week XERS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XERS News Sentiment▼0.180.36▲Average Medical News Sentiment XERS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XERS Articles This Week▼71▲XERS Articles Average Week Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PYXS News VTYX News AKBA News VSTM News RAPT News NKTR News HOWL News INZY News AQST News ACIU News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XERS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.